Cmps stock forecast.

What is the current Price Target and Forecast for COMPASS Pathways (CMPS) COMPASS Pathways (CMPS) (Delayed Data from NSDQ) $5.93 USD -0.05 (-0.84%) Updated Nov 29, 2023 04:00 PM ET...Nov 29, 2023 · According to the issued ratings of 5 analysts in the last year, the consensus rating for COMPASS Pathways stock is Buy based on the current 5 buy ratings for CMPS. The average twelve-month price prediction for COMPASS Pathways is $46.83 with a high price target of $120.00 and a low price target of $19.00. Learn more on CMPS's analyst rating ... Market Activity. Funds + ETFs. Analyst ratings can be used in addition to other personal research work prior to making investment decisions. Do Not Sell My Personal Information (CA Residents Only ...COMPASS Pathways (NASDAQ:CMPS) is a mental health care company that develops COMP360, a psilocybin therapy for depression and other conditions. The company has a consensus rating of Buy and a price target of $45.00, up from $5.65. See the latest news, earnings, dividends, and financials for CMPS stock.

Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The ...Based on short-term price targets offered by 34 analysts, the average price target for Nvidia comes to $647.12. The forecasts range from a low of $460.00 to a high of $1,100.00. The average price ...

The P/E ratio on projected 2023 earnings is 23, above the market multiple. Earnings are expected to grow 14.5% in 2023 after having fallen 3.3% in 2022. Earnings rose 37.9% in 2021 and 7.7% in ...

A high-level overview of COMPASS Pathways plc (CMPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.What this means: InvestorsObserver gives Compass Pathways Plc ADR (CMPS) an overall rank of 34, which is below average. Compass Pathways Plc ADR is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.GGB Earnings Forecast. Next quarter’s earnings estimate for GGB is $0.17 with a range of $0.14 to $0.20. The previous quarter’s EPS was $0.19. GGB beat its EPS estimate 50.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 65.34% of the time in the same period.The head of COMPASS Pathways (CMPS) contended that investors should keep in mind the positive results displayed in a recent clinical trial of its psychedelics-based treatment for depression.

CMPS Stock Forecast. TradingView. CMPS is trading in a sideways channel between $7.67 and $11.17 and will likely continue to trade in this channel until a strong catalyst pushes it out.

Real time Compass Pathways Plc (CMPS) stock price quote, stock graph, news & analysis.

-1.40 Crude Oil (-0.32%) Gold COMPASS Pathways plc (CMPS) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 5.93 -0.05 (-0.84%) At close: 04:00PM EST 6.03 +0.10 (+1.69%)...Compass Pathways PLC Follow Share $5.83 After Hours: $6.12 (4.97%) +0.29 Closed: Nov 21, 6:09:39 PM GMT-5 · USD · NASDAQ · Disclaimer search Compare to Mind Medicine (MindMed) Inc $2.68 MNMD2.55%... The 5 analysts offering 1 year price forecasts for CMPS have a max estimate of — and a min estimate of —. Analyst rating Based on 7 analysts giving stock ratings to CMPS in the past 3 months. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per …Checkpoint Therapeutics (CKPT) Stock Forecast & Price Target

Past 5 Years (per annum) N/A. N/A. N/A. N/A. See COMPASS Pathways plc (CMPS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.Nov 29, 2023 · According to 4 analysts, the average rating for ATAI stock is "Strong Buy." The 12-month stock price forecast is $13.5, which is an increase of 1,110.76% from the latest price. A high-level overview of COMPASS Pathways plc (CMPS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.The stock spiked 2.01% in intraday trading to $6.10 this Friday, 12/01/23, hitting a weekly high. The stock’s 5-day price performance is -5.43%, and it has moved by 5.54% in 30 days. Based on these gigs, the overall price performance for the year is -40.78%. The short interest in Compass Pathways Plc ADR (NASDAQ:CMPS) is 3.91 million shares ...Aug 30, 2022 · Wall Street’s 12-month median price forecast for ATAI stock stands at $24.50. Compass Pathways (CMPS) ... CMPS stock is down 30% YTD. Shares are trading at 3.3x book value.

Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Compass Inc have a median target of 2.70, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate ...Oct 30, 2023 · Nikkei 225. 30,696.96. -0.95%. Negative. Source: LSEG - data delayed by at least 15 minutes. Get Compass Pathways PLC (CMPS.OQ) real-time stock quotes, news, price and financial information from ...

View a financial market summary for CMPS including stock price quote, trading volume, volatility, options volume, statistics, and other important company ...Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression, and launches new research center. Read more. Compass is a biotechnology company dedicated to accelerating patient access and experience to evidence-based innovation in mental health care.NasdaqGS:CMPS Earnings and Revenue Growth April 12th 2021. ... Quite a few analysts cover the stock, so you could look into forecast growth quite easily. Insider Ownership Of COMPASS Pathways.Profile. Sector. Electronic Technology. Industry. Telecommunications Equipment. No executives to display. Corporate headquarters. --, --. Find real-time LLAP - Terran Orbital Corp stock quotes ...17 окт. 2022 г. ... Sustaining price action below $10, CMPS closed out the week at $9.31 ... Perhaps the lack of demand for CMPS stock is presently related to CMPS ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The ...

CLNN Stock 12 Months Forecast. $5.33. (1116.89% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Clene in the last 3 months. The average price target is $5.33 with a high forecast of $7.00 and a low forecast of $4.00. The average price target represents a 1116.89% change from the last price of $0.44.

We explain how to buy Compass Pathways Plc stock, compare the best stock trading platforms and use a detailed analysis to learn about (CMPS).

Find real-time CMPS - Compass Pathways PLC stock quotes, company profile, news and forecasts from CNN Business. In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.Stock Price Forecast. The 9 analysts offering 12-month price forecasts for Genco Shipping & Trading Ltd have a median target of 19.80, with a high estimate of 27.00 and a low estimate of 15.00 ...17 окт. 2022 г. ... Sustaining price action below $10, CMPS closed out the week at $9.31 ... Perhaps the lack of demand for CMPS stock is presently related to CMPS ...May 11, 2023 · In the last 3 months, 5 analysts have offered 12-month price targets for Compass Pathways. The company has an average price target of $50.6 with a high of $120.00 and a low of $19.00. Below is a ... Gujarat Mineral Development Corporation Ltd., incorporated in the year 1963, is a Small Cap company (having a market cap of Rs 13,265.37 Crore) operating in Mining sector. Gujarat Mineral Development Corporation Ltd. key Products/Revenue Segments include Lignite, Thermal Power, Renewable Energy ...Acm Research Inc Stock Forecast, Predictions & Price Target. Add to Watchlist. Overview Forecast. Earnings Dividend Ownership. Analyst price target for ACMR. All Analysts Top Analysts. Based on 3 analysts offering 12 month price targets for Acm Research Inc. Min Forecast. $18.00 +8.17%. Avg Forecast. $24.47 +47.04%.Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Compass Minerals International Inc have a median target of 43.50, with a high estimate of 82.00 and a low estimate of 36. ...An in-depth look at the leading psychedelic stocks in the U.S stock market this year. ... Compass Pathways (NASDAQ:CMPS) $350.9 million Developing one psilocybin therapy, COMP360.

Compass Pathways Plc - ADR Stock Price Forecast, "CMPS" Predictons for20233 brokers have issued twelve-month price targets for eXp World's shares. Their EXPI share price targets range from $14.00 to $28.00. On average, they anticipate the company's share price to reach $21.00 in the next year. This suggests a possible upside of 70.9% from the stock's current price. View analysts price targets for EXPI or view top ...Based on 8 analysts giving stock ratings to CMPS in the past 3 months. Neutral. SellBuy. Strong sell ...Instagram:https://instagram. low stocks todaytransfer etrade accountoffice space reitsbest investment for 5k 17 окт. 2022 г. ... Sustaining price action below $10, CMPS closed out the week at $9.31 ... Perhaps the lack of demand for CMPS stock is presently related to CMPS ... best brokerage account canadavw stocks Analyst Forecast According to 5 analysts, the average rating for CMPS stock is "Strong Buy." The 12-month stock price forecast is $49.6, which is an increase of 736.43% from the latest price. uipath price COMPASS Pathways PLC (CMPS) stock is down -1.77% while the S&P 500 is higher by 1.89% as of 2:59 PM on Thursday, Apr 27. CMPS has fallen -$0.15 from the previous closing price of $8.17 on volume of 236,713 shares. Over the past year the S&P 500 has fallen -1.22% while CMPS has fallen -21.27%.VIR Stock 12 Months Forecast. $32.86. (233.94% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Vir Biotechnology in the last 3 months. The average price target is $32.86 with a high forecast of $95.00 and a low forecast of $14.00. The average price target represents a 233.94% change from the last price of $9.84.Market caps as of Oct. 23, 2023. Company. Market Cap. Description. Atai Life Sciences ( NASDAQ:ATAI ) $215.8 million. Developing multiple drugs based on psychedelic substances, including ibogaine ...